COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN

被引:1
|
作者
Mesterton, J. [1 ]
By, A. [2 ]
Sandelin, R. [2 ]
Jonsson, L. [1 ]
机构
[1] i3 Innovus, Stockholm, Sweden
[2] Pfizer AB, Sollentuna, Sweden
关键词
D O I
10.1016/S1098-3015(10)74816-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A369 / A369
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease
    Neumann, PJ
    Hermann, RC
    Kuntz, KM
    Araki, SS
    Duff, SB
    Leon, J
    Berenbaum, PA
    Goldman, PA
    Williams, LW
    Weinstein, MC
    NEUROLOGY, 1999, 52 (06) : 1138 - 1145
  • [2] COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE
    Chyr, L. C.
    Yapici, H. O.
    Padula, W., V
    VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [3] Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
    Lopez-Bastida, Julio
    Hart, Warren
    Garcia-Perez, Lidia
    Linertova, Renata
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 399 - 407
  • [4] COST-EFFECTIVENESS OF ADUCANUMAB VERSUS DONEPEZIL FOR PATIENTS WITH EARLY ALZHEIMER'S DISEASE
    Xiong, X.
    Li, M.
    Lu, Z. K.
    VALUE IN HEALTH, 2023, 26 (06) : S85 - S85
  • [5] COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
    Getsios, D.
    Blume, S.
    Ishak, K. J.
    MacLaine, G.
    VALUE IN HEALTH, 2009, 12 (03) : A191 - A191
  • [6] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [7] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336
  • [8] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
    Stefan J. Teipel
    Michael Ewers
    Veronika Reisig
    Bernd Schweikert
    Harald Hampel
    Michael Happich
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 330 - 336
  • [9] Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (01) : 73 - 78
  • [10] The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease:: A Markov model
    Jönsson, L
    Lindgren, P
    Wimo, A
    Jönsson, B
    Winblad, B
    CLINICAL THERAPEUTICS, 1999, 21 (07) : 1230 - 1240